Munsch, Gaëlle
Goumidi, Louisa
van Hylckama Vlieg, Astrid
Ibrahim-Kosta, Manal
Bruzelius, Maria
Deleuze, Jean-François
Rosendaal, Frits R.
Jacqmin-Gadda, Hélène
Morange, Pierre-Emmanuel
Trégouët, David-Alexandre
Funding for this research was provided by:
Agence Nationale de la Recherche (EPIDEMIOM-VT, ANR-10-LABX-0013, Program Hospitalier de la Recherche Clinique, EPIDEMIOM-VT)
Netherlands Heart Foundation (NHS98.113)
Dutch Cancer Foundation (RUL 99/1992)
Netherlands Organization for Scientific Research
Article History
Received: 11 April 2022
Accepted: 4 April 2023
First Online: 22 April 2023
Declarations
:
: Research have been performed in accordance with the Declaration of Helsinki. The MARTHA study was initially approved by the local ethic committee “Mediterranean I Committee for the Protection of Individuals” (reference: 12 61). The MEGA study was approved by the local ethic committee “Medical Ethics Committee of the Leiden University Medical Center”.All experimental protocols to study the genetics of VT recurrence were approved by the local ethic committee “Mediterranean I Committee for the Protection of Individuals” (reference: 12 61) for MARTHA and by the local ethic committee “Medical Ethics Committee of the Leiden University Medical Center” for MEGA.Written informed consent to participate was obtained from all MARTHA and MEGA participants.
: Not applicable.
: The authors declare that they have no competing interests.